Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKG.L Regulatory News (SKG)

  • There is currently no data for SKG

Form 38.5(a) - Amendment

5 Jun 2018 16:13

RNS Number : 3952Q
Citigroup Global Markets Limited
05 June 2018
 

 

Amendment: Changes to Section 2 (a) and (b)

 

FORM 38.5(a)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 

Name of exempt principal trader

Citigroup Global Markets Limited

Company dealt in

Smurfit Kappa Group plc

Class of relevant security to which the dealings being disclosed relate (Note 1)

0.001 Ordinary Shares

Date of dealing

31 May 2018

 

2. DEALINGS (Note 2)

 

(a) Purchases and sales

 

Total number of relevant securities acquired

Highest price paid

 

Lowest price paid

1,796,796

EUR 35.8600

EUR 34.7400

52,775

GBP 31.0400

GBP 30.6215

Total number of securities disposed

Highest price received

 

Lowest price received

1,844,842

EUR 35.9800

EUR 34.7800

52,484

GBP 31.0200

GBP 30.6288

 

 

 

 

 

 

 

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 4)

Number of relevant securities

(Note 5)

Price per unit

(Note 3)

TRS

Reducing short position

1,205

EUR 35.71257

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 3)

 

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 3)

 

 

3.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities 

under any option referred to on this form or relating to the voting rights or future 

acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

Date of disclosure

05 June 2018

Contact name

 Cathal McKenna

Telephone number

00 44 (0)28 90409544

Name of offeree/offeror with which connected

Smurfit Kappa Group plc

Nature of connection (Note 6)

 Financial Advisor

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ISELLFLERIIEIIT
Date   Source Headline
29th Feb 20244:42 pmRNSTotal Voting Rights
26th Feb 20249:51 amRNSHolding(s) in Company
21st Feb 20245:16 pmRNSHolding(s) in Company
19th Feb 20249:35 amRNSBlock listing Interim Review
16th Feb 20245:05 pmRNSDirector/PDMR Shareholding
14th Feb 202412:08 pmRNSHolding(s) in Company
14th Feb 202411:08 amRNSHolding(s) in Company
13th Feb 202412:22 pmRNSHolding(s) in Company
6th Feb 20244:14 pmRNSHolding(s) in Company
6th Feb 202412:19 pmRNSHolding(s) in Company
2nd Feb 20245:13 pmRNSHolding(s) in Company
2nd Feb 202412:38 pmRNSHolding(s) in Company
1st Feb 20245:26 pmRNSHolding(s) in Company
30th Jan 20243:44 pmRNSHolding(s) in Company
30th Jan 20243:35 pmRNSHolding(s) in Company
11th Jan 20249:48 amRNSHolding(s) in Company
5th Jan 20244:42 pmRNSHolding(s) in Company
2nd Jan 20242:02 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSHolding(s) in Company
2nd Jan 20247:00 amRNSHolding(s) in Company
27th Dec 20237:00 amRNSHolding(s) in Company
21st Dec 20232:38 pmRNSHolding(s) in Company
19th Dec 20234:01 pmRNSHolding(s) in Company
14th Dec 202311:01 amRNSHolding(s) in Company
11th Dec 202311:17 amRNSHolding(s) in Company
8th Dec 20233:41 pmRNSHolding(s) in Company
7th Dec 202312:30 pmRNSHolding(s) in Company
6th Dec 20235:04 pmRNSHolding(s) in Company
6th Dec 202310:12 amRNSHolding(s) in Company
1st Dec 20234:11 pmRNSDirector/PDMR Shareholding
1st Dec 20232:34 pmRNSHolding(s) in Company
1st Dec 20239:59 amRNSHolding(s) in Company
28th Nov 20235:10 pmRNSHolding(s) in Company
27th Nov 202312:47 pmRNSHolding(s) in Company
24th Nov 202310:12 amRNSHolding(s) in Company
23rd Nov 20233:36 pmRNSHolding(s) in Company
22nd Nov 20235:28 pmRNSHolding(s) in Company
20th Nov 202312:41 pmRNSHolding(s) in Company
15th Nov 20233:50 pmRNSHolding(s) in Company
9th Nov 20234:20 pmRNSDirector/PDMR Shareholding
6th Nov 20239:50 amRNSHolding(s) in Company
3rd Nov 202310:27 amRNSHolding(s) in Company
1st Nov 20237:00 amBUSTrading Statement
31st Oct 202312:40 pmRNSHolding(s) in Company
30th Oct 20233:22 pmRNSHolding(s) in Company
27th Oct 20232:24 pmRNSHolding(s) in Company
26th Oct 202310:22 amRNSHolding(s) in Company
24th Oct 20235:25 pmRNSHolding(s) in Company
24th Oct 20239:32 amRNSHolding(s) in Company
23rd Oct 20231:59 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.